Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Prasco Laboratories has entered into a supply agreement with Japan-based Shionogi, engaged in research, development, manufacturing, and marketing activities, with a primary focus on prescription drugs.
Subscribe to our email newsletter
As per the terms of the deal, Prasco is responsible for marketing and distributing the Authorized Generic version of Ponstel, Mefenamic Acid Capsules, USP 250mg.
Ponstel is a member of the fenamate group of nonsteroidal anti-inflammatory drugs (NSAIDs).
Prasco CEO Thomas Arington said with the introduction of the authorized generic of Shionogi’s Ponstel, Prasco continues to be the preferred partner for established brand companies to transcend their brands with their Authorized Generics.